Robert Liptak Net Worth

The estimated Net Worth of Robert Liptak is at least $12.3 millió dollars as of 4 January 2016. Robert Liptak owns over 15,300 units of Globus Medical Inc stock worth over $2,851,084 and over the last 12 years Robert sold GMED stock worth over $9,459,229.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Robert Liptak GMED stock SEC Form 4 insiders trading

Robert has made over 3 trades of the Globus Medical Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Robert exercised 15,300 units of GMED stock worth $234,702 on 4 January 2016.

The largest trade Robert's ever made was selling 804,232 units of Globus Medical Inc stock on 8 August 2012 worth over $8,975,229. On average, Robert trades about 70,378 units every 104 days since 2012. As of 4 January 2016 Robert still owns at least 41,159 units of Globus Medical Inc stock.

You can see the complete history of Robert Liptak stock trades at the bottom of the page.

What's Robert Liptak's mailing address?

Robert's mailing address filed with the SEC is VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403.

Insiders trading at Globus Medical Inc

Over the last 12 years, insiders at Globus Medical Inc have traded over $375,265,297 worth of Globus Medical Inc stock and bought 2,005 units worth $99,824 . The most active insiders traders include David C Paul, Kurt Wheeler és David M Demski. On average, Globus Medical Inc executives and independent directors trade stock every 42 days with the average trade being worth of $11,005,133. The most recent stock trade was executed by Leslie V Norwalk on 11 July 2024, trading 1,000 units of GMED stock currently worth $70,000.

What does Globus Medical Inc do?

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.

Complete history of Robert Liptak stock trades at Globus Medical Inc

Globus Medical Inc executives and stock owners

Globus Medical Inc executives and other stock owners filed with the SEC include:

• David Demski,
  President, Chief Executive Officer, Director
• David Paul,
  Executive Chairman of the Board
• Daniel Scavilla,
  Executive Vice President, Chief Commercial Officer
• David M. Demski,
  CEO, Pres & Director
• Kelly Huller,
  Senior Vice President, General Counsel, Corporate Secretary
• David C. Paul,
  Co-Founder & Exec. Chairman
• Daniel T. Scavilla,
  Exec. VP, Chief Commercial Officer & Pres of Trauma
• Keith Pfeil,
  Chief Financial Officer, Senior Vice President
• Keith W. Pfeil,
  Sr. VP & CFO
• Kelly G. Huller Esq.,
  Sr. VP & Gen. Counsel
• Ann Rhoads,
  Independent Director
• Robert Douglas,
  Independent Director
• James Tobin,
  Independent Director
• Daniel Lemaitre,
  Independent Director
• Steve Zarrilli,
  Independent Director
• David Davidar,
  Independent Director
• Richard Holifield,
  Exec. Officer
• Mike Reeder,
  Exec. Officer
• Steven M. Payne,
  VP & Controller
• A. Brett Murphy,
  Exec. VP of International Sales
• Brian J. Kearns,
  Sr. VP of Bus. Devel. & Investor Relations
• John A De Ford,
  
• Kurt Wheeler,
  Director
• Robert Liptak,
  Director
• Steven Payne,
  Chief Accounting Officer
• Anthony L Williams,
  President
• Stephen T Zarrilli,
  
• Leslie V Norwalk,
  
• Dan Wolterman,
  
• Dan Lemaitre,
  
• A Brett Murphy,
  Executive VP, US Sales
• Eric Schwartz,
  Senior VP and General Counsel
• Sachs & Cogoldman Sachs Gro...,
  
• Lifesciences I, L.P.Clarus ...,
  
• Sachs Pep 2004 Offshore Hol...,
  
• Richard A Baron,
  Senior VP and CFO
• Sachs Group Incgoldman Sach...,
  
• Sachs Private Equity Partne...,